United States of America
Peter Fellner was appointed as Chairman in April 2003. Peter was Chairman of Celltech Group plc until its acquisition in mid-2004, having previously served as its Chief Executive Officer from 1990 to 2003. Before Celltech, Peter was Chief Executive Officer of Roche UK, from 1986 to 1990. Peter is also Chairman of the medical technology company Consort Medical plc and of the biotechnology company, Ablynx nv. In addition, he is Chairman of Mereo Biopharma Group plc, which was listed on AIM in June 2016. He was Chairman of Optos plc from 2010 to 2015, until its acquisition by Nikon Corporation, and served as Chairman of Biotie Therapies Corp from 2010 to 2014.
He was a Director of the global biopharmaceutical company, UCB S.A from 2005 to 2014, and was also a member of the UCB Science Advisory Board. He was also a member of the Novo A/S Advisory Group from 2010 to 2016. Peter was previously Chairman of Acambis plc and of Premier Research Group plc, until each was acquired during 2008 and was Vice Chairman of Astex Pharmaceuticals Inc. until its sale in October 2013. Peter served as a director of Evotec AG, from 2005 to 2011, and QinetiQ Group plc from 2004 to 2009.